Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-086184
Filing Date
2025-09-09
Accepted
2025-09-09 16:30:40
Documents
15
Effectiveness Date
2025-09-09

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0256173-s8_pasithea.htm S-8 31701
2 OPINION OF LOWENSTEIN SANDLER LLP ea025617301ex5-1_pasithea.htm EX-5.1 6611
3 CONSENT OF CBIZ CPAS P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PASI ea025617301ex23-1_pasithea.htm EX-23.1 1842
4 FILING FEE TABLE ea025617301ex-fee_pasithea.htm   iXBRL EX-FILING FEES 14029
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3980
  Complete submission text file 0001213900-25-086184.txt   182232

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ea025617301ex-fee_pasithea_htm.xml XML 5096
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290135 | Film No.: 251303650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)